← All use cases

Accelerate image review

Automate preclinical image analysis

Preclinical Vision Pilot Indirect

Computer vision highlights and quantifies tissue changes in preclinical images so scientists can focus review on relevant findings.

Scientist examining imaging data in a laboratory
(01) The opportunity

Why this use case matters.

Manual review of large imaging studies is time-consuming and can vary between reviewers.

Faster analysis, more consistent measurement, and shorter preclinical study cycles.

Primary user
Toxicology Pathologist
Business process
Toxicology image assessment
Primary technology
Computer Vision
Human responsibility
Confirm findings, review edge cases, and make the scientific interpretation
(02) How it works

From data to a human decision.

The technology supports a defined workflow. It does not replace the accountable professional.

01

Inputs and data

Histology slides, microscopy images, and validated annotations

02

AI capability

Segments tissue, detects candidate changes, and produces quantitative measurements

03

Output and action

Annotated images and review-ready quantitative metrics

(03) Use case evaluation

Value versus effort.

This indicative view balances potential business value with the effort required to implement and operate the use case.

Selected use case Other use cases
(04) Responsible implementation

Risks and controls.

The value depends on a workflow that makes risk visible and preserves human accountability.

Risk areas

  • Missed findings
  • Model-performance drift
  • Non-representative training data

Practical controls

  • Pathologist confirmation
  • Routine performance audits
  • Controlled datasets and change management
Evaluate it in your context

Is this use case worth pursuing for your organization?

Let’s talk